These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9916332)

  • 61. Active drug safety surveillance: a tool to improve public health.
    Platt R; Madre L; Reynolds R; Tilson H
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1175-82. PubMed ID: 18823068
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Drug-eruptions].
    Thielen AM; Toutous-Trellu L; Desmeules J
    Rev Med Suisse; 2008 Jul; 4(165):1671-5. PubMed ID: 18767294
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Pharmacovigilance of vaccines].
    Autret-Leca E; Bensouda-Grimaldi L; Jonville-Béra AP; Beau-Salinas F
    Arch Pediatr; 2006 Feb; 13(2):175-80. PubMed ID: 16343870
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Research methods in drug surveillance.
    Engel RR; Grohmann R; Rüther E; Hippius H
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S12-5. PubMed ID: 15052510
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Adverse effects of Disulone; results of the France pharmacovigilance inquiry. Regional Centers of Pharmacovigilance].
    Benedetti-Bardet C; Guy C; Boudignat O; Regnier-Zerbib A; Ollagnier M;
    Therapie; 2001; 56(3):295-9. PubMed ID: 11475811
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations.
    Brown JS; Kulldorff M; Petronis KR; Reynolds R; Chan KA; Davis RL; Graham D; Andrade SE; Raebel MA; Herrinton L; Roblin D; Boudreau D; Smith D; Gurwitz JH; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):226-34. PubMed ID: 19148879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
    Sever JL; Brenner AI; Gale AD; Lyle JM; Moulton LH; West DJ;
    Pharmacoepidemiol Drug Saf; 2002; 11(3):189-202. PubMed ID: 12051118
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health].
    Micallef J; Jouanjus É; Mallaret M; Lapeyre Mestre M
    Therapie; 2019 Dec; 74(6):579-590. PubMed ID: 31694770
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Postmarketing surveillance-one of the key issues in drug development.
    Székely G; Görgényi F
    Ther Hung; 1992; 40(4):147-53. PubMed ID: 1345020
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Computerized detection of new adverse effects in drug surveillance. A proposal for the periodic use of the French data bank].
    Pham E; Ventre JJ; Saddier P; Descotes J; Evreux JC
    Therapie; 1988 May; 43(3):235-7. PubMed ID: 3420571
    [No Abstract]   [Full Text] [Related]  

  • 72. The quantification of drug risks in practice.
    Lee D; Bergman U
    WHO Reg Publ Eur Ser; 1993; 45():79-95. PubMed ID: 8442852
    [No Abstract]   [Full Text] [Related]  

  • 73. From the monitoring of severe to a survey of mild adverse effects of current antihypertensive therapy: the hidden side of the iceberg. The Scientific Committee of the Italian Pharmacoepidemiology Survey on Antihypertensive Therapy.
    Zanchetti A; Ambrosioni E; Pessina A; Trimarco B
    Blood Press Suppl; 1997; 1():40-1. PubMed ID: 9285107
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacoepidemiology and gastroenterology: a close couple.
    Leufkens HG
    Scand J Gastroenterol Suppl; 2000; (232):105-8. PubMed ID: 11232486
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Surveillance and detection of unusual events in toxicovigilance: Review of relevant methods].
    Faisandier L; Fouillet A; Bicout DJ; Golliot F; Ahmed I; Bringay S; Eilstein D
    Rev Epidemiol Sante Publique; 2015 Apr; 63(2):119-31. PubMed ID: 25819992
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of pharmacoepidemiology research in postmarketing surveillance and anesthesia practice/critical care medicine.
    Grasela TH; Watkins WD; Hug CC; McLeskey CH; Nahrwold ML; Roizen MF; Stanley TH; Thisted RA; Walawander CA; White PF
    Anesth Analg; 1993 Oct; 77(4 Suppl):S44-50. PubMed ID: 8214697
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Drug information and prescription guidance: role of regional centers of pharmacovigilance].
    Blayac JP; Haramburu F; Lerebours S; Vial T
    Presse Med; 2000 Jan; 29(2):115-8. PubMed ID: 10682043
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Good practices in pharmacovigilance. Drugs for human use].
    Therapie; 1995; 50(6):547-55. PubMed ID: 8745955
    [No Abstract]   [Full Text] [Related]  

  • 79. [Pharmacovigilance in practice].
    Spreux A; Baldin B; Chichmanian RM
    Transfus Clin Biol; 1999 Jul; 6(4):254-9. PubMed ID: 10472690
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria.
    Shakir SA; Layton D
    Drug Saf; 2002; 25(6):467-71. PubMed ID: 12071785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.